Abiopharma

Donaldson Company Increases Quarterly Cash Dividend 6.7%

UPWK Investors Have Opportunity to Join Upwork Inc. Fraud Investigation with the Schall Law Firm

ISS and Glass Lewis Support BIMIZCI’s Case for Change at Medallion Financial. Both Recommend Stockholders Vote on the BLUE Proxy Card FOR Election of Two BIMIZCI Nominees to Medallion Board

Sallie Mae Co-President and CFO to Speak at 2026 Morgan Stanley US Financials Conference

Powerfleet to Attend June Investor Conferences

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split

Clinical trial NCT06630299 updates: 1. primary completion date: 2026-04-01 → 2026-04-23 2. enrollment: not set → 600 participants

Clinical trial NCT06846671: enrollment: not set → 250 participants.

Clinical trial NCT06952530 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 487 participants